Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern DevicesNew HRS data extends EHRA findings with a specific analysis of next-gen ILRs, demonstrating that, on top of manufacturer-embedded AI, Implicity filters out 61.6% of false positives while maintaining 98.3% sensitivity
From Next-Generation Mobility to Global Expansion: iCAUR Demonstrated Its Vision at Beijing Auto Show 2026BEIJING, April 25, 2026 (GLOBE NEWSWIRE) -- The Beijing Auto Show 2026, which opened on April 24, marked a key moment for Chery Group’s iCAUR as the brand presented two major highlights: the ROBOX concept car and the right-hand-drive (RHD) version of the V27. Both were presented by Dr. Su Jun, CEO of iCAUR.
CGTN: The Art of Governance: How China is shaping a new path for sustainable developmentBEIJING, April 25, 2026 (GLOBE NEWSWIRE) -- As the world grapples with achieving sustainable economic growth, China is successfully using technology to boost people's livelihoods while also preserving the environment.
Fairfax Announces Conference CallTORONTO, April 24, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) will hold a conference call at 8:30 a.m. Eastern Time on Friday, May 1, 2026 to discuss its 2026 first quarter results, which will be announced after the close of markets on Thursday, April 30, 2026 and will be available at that time on its website at www.fairfax.ca. The call, consisting of a presentation by the company followed by a question period, may be accessed at 1 (800) 369-2143 (Canada and U.S.) or 1 (312) 470-0063 (International) with the passcode “FAIRFAX”.
Rivalry Announces Board and Management ChangesTORONTO, April 24, 2026 (GLOBE NEWSWIRE) -- Rivalry Corp. (TSXV: RVLY) (the “Company” or “Rivalry”) today announced changes to its board of directors and management as part of the Company’s ongoing operational transition.
BGIN BLOCKCHAIN LIMITED Reports Unaudited Financial Results for the Full Year of 2025SINGAPORE, April 25, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and a manufacturer of cryptocurrency mining hardware, today released its unaudited financial results for the year ended December 31, 2025.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 36,447 restricted stock units of the company’s common stock to 12 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of April 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference CallMINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (
NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the quarter ended March 31, 2026 after market close on Wednesday, May 13, 2026.The Company will host a conference call to discuss these results the next day on Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
Ebang International Reports Financial Results for Fiscal Year 2025IRVING, Texas, April 24, 2026 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we” or “our”), today announced its financial results for the fiscal year ended December 31, 2025.
Crescent Biopharma Announces Grants of Inducement AwardsWALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company’s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on April 23, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).
UTStarcom Files 2025 Form 20-FHANGZHOU, China, April 24, 2026 (GLOBE NEWSWIRE) -- UTStarcom (“UT” or the “Company”) (
NASDAQ: UTSI), a global telecommunications infrastructure provider, today filed its Annual Report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission.
Altus Group Announces Completion of Substantial Issuer BidTORONTO, April 24, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today announced that it has taken up and paid for 3,846,153 of its common shares (“Shares”) at a price of C$52.00 per Share (the “Purchase Price”) under Altus Group’s substantial issuer bid (the “SIB”) to repurchase for cancellation a number of its Shares for an aggregate purchase price not to exceed C$200 million.
Middlesex Water Company Declares Quarterly Cash DividendISELIN, N.J., April 24, 2026 (GLOBE NEWSWIRE) -- Middlesex Water Company (
NASDAQ: MSEX) announced today that its Board of Directors has declared a quarterly cash dividend of $0.36 per share on its common stock, payable June 1, 2026 to shareholders of record as of May 15, 2026. Middlesex has paid cash dividends in varying amounts continually since 1912.
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive OrderAgency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach ClaimSAN DIEGO, April 24, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that the Delaware Chancery Court has dismissed Tesaro’s anticipatory breach of contract claim against Anaptys. The ruling agrees with Anaptys’ position that it has never repudiated the Collaboration and Exclusive License Agreement (“Collaboration Agreement”) with Tesaro, a subsidiary of GSK, governing the development and commercialization of Jemperli.
SBA Sends 562,000 Suspected Fraudulent Loans to Treasury for Collections Totaling $22 BillionWhite House Task Force to end Biden Administration amnesty for fraudulent pandemic-era loans, pursue historic collection
Biotech startup Plopii Files US Patent on the Next-Generation Headache PillBrooklyn biotech files 40-claim patent application covering a new active-ingredient combination for over-the-counter headache relief
The Deal Closers Expands Deployment of Its Done-For-You Client Acquisition System Across U.S. Tax Advisory FirmsNew York, NY, April 24, 2026 (GLOBE NEWSWIRE) -- The Deal Closers, a U.S.-based marketing and sales execution firm, announced the continued expansion of its proprietary client acquisition system across firms operating specifically in the tax planning and advisory space.
Gemini to Announce First Quarter 2026 Results on May 14, 2026NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Gemini Space Station, Inc. (“Gemini”) (
NASDAQ: GEMI), a global crypto and prediction markets platform, today announced it will release its first quarter 2026 financial results after market close on Thursday, May 14, 2026. Management will host a conference call on Friday, May 15, 2026 at 8:30 a.m. ET to discuss the results.
SEGG Media Enters Sports Predictions Market via Sports.com PredictFORT WORTH, Texas, April 24, 2026 (GLOBE NEWSWIRE) -- Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG, LTRYW) (the “Company” or “SEGG Media”) today announced the launch of Sports.com Predict, marking the Company’s entry into the rapidly growing prediction markets space. The initiative will be developed and operated through Sports Predicts Limited, a SEGG Media company, and integrated into the Sports.com platform.
ComfyUI Raises $30M at $500M Valuation to Scale Open-Source AI for Creative ProductionOpen-source AI workflow platform surpasses 4M users and 50K daily downloads as investors back creator-first infrastructure
Bragar Eagel & Squire, P.C. Urges ChowChow Cloud International Holdings Limited Investors to Contact the Firm Before May 12thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CHOW To Contact Him Directly To Discuss Their Options
Mount Sinai Health System and Guyana Ministry of Health Host Seminar on Practical, Responsible Integration of Artificial Intelligence in Health CareGeorgetown, Guyana, April 24, 2026 (GLOBE NEWSWIRE) -- The Mount Sinai Health System and the Guyana Ministry of Health yesterday convened government, clinical, operational, and artificial intelligence (AI) leaders for a seminar, “Turning Promise Into Practice: Integrating AI Into Health Care—Foundations, Ethics, and Decision-Making,” in Georgetown, Guyana.
Super Micro Computer, Inc. Investors Have Until May 26th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Super Mirco (SMCI) To Contact Him Directly To Discuss Their Options
FRANKLIN BSP REALTY TRUST DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urges Franklin BSP Realty Trust Investors with Large Losses to Contact the Firm Before April 27thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Franklin BSP Realty Trust (FBRT) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors with Large Losses to Contact the Firm Regarding Their Rights Before May 29thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aldeyra (ALDX) To Contact Him Directly To Discuss Their Options
Transaction in Own SharesTransaction in Own Shares
NEW ERA ENERGY LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Urges New Era Energy & Digital, Inc. Investors with Large Losses to Contact the Firm Before June 1stBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In New Era Energy (NUAI) To Contact Him Directly To Discuss Their Options
Distributed Energy Clearinghouse™ Re-Elects David Roylance to the Board of DirectorsHOUSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Distributed Energy Clearinghouse™, a leading provider of distributed energy analytics and advisory services, has announced that energy industry veteran David Roylance has been re-elected to its Board of Directors.
Happy Renters, Better Performance: Why Resident Experience Matters Most in Today’s MarketResidents satisfied with their move-in are 31% more likely to renew their leases, underscoring the importance of early experiences in driving long-term property performance
Sportradar Reschedules Its First Quarter 2026 Financial and Operating Results to April 28, 2026ST. GALLEN, Switzerland, April 24, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (Nasdaq: SRAD) (“Sportradar”) today announced it has changed the date of its previously scheduled first quarter earnings call.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Helix Energy Solutions Group, Inc. (NYSE – HLX), TopBuild Corp. (NYSE – BLD), Avanos Medical, Inc. (NYSE – AVNS), Affinity Bancshares (Nasdaq – AFBI)BALA CYNWYD, Pa., April 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
STLA Investors Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stellantis N.V. (“Stellantis” or “the Company”) (
NYSE: STLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Upstart Holdings, Inc. (“Upstart” or “the Company”) (
NASDAQ: UPST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” or “the Company”) (
NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (
NASDAQ: GOSS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
AlphaSense Named a Leader in Inaugural Gartner® Magic Quadrant™ for Competitive and Market IntelligenceMagic Quadrant has AlphaSense at the top on both axes, including Ability to Execute and Completeness of Vision, reflecting AlphaSense’s market leading position
PINS Investors Have Opportunity to Lead Pinterest, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (
NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use DisorderRICHMOND, Va., April 24, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), a leader in the treatment of opioid use disorder (OUD), will present one new scientific poster and collaborated with VA Tech on a second poster which will be presented at the American Society of Addiction Medicine (ASAM) Annual Conference, held April 23-26, 2026, in San Diego, California. The data add to the growing body of evidence evaluating extended-release buprenorphine, a monthly injectable commercially available as SUBLOCADE®, in supporting meaningful outcomes for people living with OUD, including overdose-related outcomes and broader indicators associated with recovery.
Qosina Hosts Educational Lunch & Learn Event in Partnership with Packaging Compliance LabsRonkonkoma, April 24, 2026 (GLOBE NEWSWIRE) -- Qosina, a leading global supplier of single-use components for the medical and pharmaceutical industries, will host a private educational event in collaboration with Packaging Compliance Labs (PCL) on April 30, 2026, at Texas Medical Center in Houston, TX. Designed for engineers and product developers, the event will deliver practical insights to support more efficient product development.
Former Toyota Executive Mentors High Point University StudentsHIGH POINT, N.C., April 24, 2026 (GLOBE NEWSWIRE) -- High Point University students learned how motivation and personal goals can help navigate their professional careers from Sean Suggs, HPU’s Technology Executive in Residence and former president of Toyota Battery Manufacturing North Carolina, during his recent visit to campus.
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (
NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vital Farms, Inc. (“Vital Farms” or “the Company”) (
NASDAQ: VITL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Tony S. Kalogerakos, Esq.–Injury Lawyers (New York) Explores Legal Action on Behalf of Victims Harmed by ISIS and the Al-Nusrah FrontNEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Tony S. Kalogerakos, Esq.–Injury Lawyers announced today that its New York office is investigating potential civil claims on behalf of individuals and families harmed by ISIS and the Al-Nusrah Front, following a landmark federal criminal case and recent legal developments under U.S. anti-terrorism law.
Exclusive Ferrari Daytona SP3 Leads Spectacular Group of Ferraris at Broad Arrow’s Concorso d’Eleganza Villa d’Este Auction2023 Ferrari Daytona SP3 leads stunning selection of 20 collectable Ferrari models from 1956 to 2024 at official auction of the Concorso d’Eleganza Villa d’Este | Uniquely specified 2008 Ferrari 430 Scuderia, Blu Pozzi 2004 Ferrari 360 Challenge Stradale, manual 2004 Ferrari 612 Scaglietti and desirable 1996 Ferrari F512M also on offer | Classic Ferraris in the catalogue include 1956 Ferrari 250 GT Boano Alloy Coupe, 1968 Ferrari 330 GTS, and 1972 Ferrari 246 GT Dino | Complete digital catalogue for 16-17 May Concorso d’Eleganza Villa d’Este Auction is now live at broadarrowauctions.com
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Super Micro Computer, Inc. (“Super Micro” or “the Company”) (
NASDAQ: SMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (“ImmunityBio” or “the Company”) (
NASDAQ: IBRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Spherix Global Insights Finds Specialty Split in Perceptions of Direct-to-Patient Platforms for Obesity TreatmentHigh adoption rates for obesity treatment are noted across both LillyDirect and NovoCare platforms, but key workflow differences drive a split in preferences
COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Coty Inc. (“Coty” or “the Company”) (
NYSE: COTY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
ACTG Launches Landmark Study Evaluating Treatments for Depressive Disorders with or without Mild Neurocognitive Disorder among People Living with HIVCHAPEL HILL, N.C., April 24, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of study A5402, an important new study that researchers hope will expand understanding of how to best treat depressive disorders and mild neurocognitive disorder (MND) among people living with HIV. A5402 is a phase 2, randomized, open-label clinical trial evaluating the safety and efficacy of pramipexole (a drug that stimulates receptors for the neurotransmitter dopamine in the brain) compared to escitalopram (a traditional antidepressant that modulates serotonin, a different neurotransmitter) to treat depressive disorders with or without MND among people living with HIV.
MoneyFlare Launches an AI Stock Trading Bot to Help Investors Trade With More PrecisionMoneyFlare today announced the launch of its new AI stock trading bot, designed to help investors respond to the stock market with more speed, structure, and precision. As U.S. equities return to record territory and trading activity stays elevated, the company is positioning automated stock trading as a practical solution for investors who want faster execution and fewer emotional decisions.
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (
NASDAQ: ATRA) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
ThinkAhead Corporation Launches Diluta, the AI Productivity Platform Designed Around Human Energy PatternsA new generation of productivity technology uses chronotypes, behavioral archetypes, and adaptive AI to help people work smarter—not harder
Xcel Brands & Gemma Stafford Launch GemmaMade on QVCNEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (
NASDAQ: XELB), an industry leading media and consumer products company specializing in building influencer-driven brands through social commerce and live streaming, is excited to announce International Baking Star, chef and creator of the YouTube sensation Bigger Bolder Baking, Gemma Stafford, will be premiering GemmaMade by Gemma Stafford on QVC Sunday, April 26th, 2026.
